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The Indications for Cortisone and ACTH in Rheumatoid Arthritis By W. S. C. COPEMAN, O.B.E., M.D., F.R.C.P. IF I may summarize the experience of long-term therapy gained by my group over the last three years, I would say that cortisone and ACTH, if used properly and intelligently, can be extremely helpful, and with care need not be dangerous. Long-term maintenance presents difficulties (as do many other forms of medical therapy), but these can, in most cases, be overcome if time and trouble are taken.
We agree that under cover of long-term suppression of the symptoms of the disease structural joint changes may slowly increase, but surely this is a normal clinical risk and worth facing, if thereby the patient can be given a significant extension of pain-free and useful working life. This we have been able to achieve in 17 out of the 20 cases constituting our present trial series.
To achieve such a result, however, suitable cases must be carefully selected (some cases in recently reported trials were both unselected and had irreversible crippling present before treatment was started); and to avoid "rebound" and "withdrawal" phenomena dosage must be very gradually "tailed off" if treatment is to be stopped for any reason.
The indications for the use of cortisone and ACTH as long-term treatment we would consider to be cases of rheumatoid arthritis in which structural damage is such that function is capable of being restored to a useful degree, and which have failed to react to classical methods of treatment. There must be none of the well-recognized contra-indications present, and the patient should, if possible, be intelligent and co-operative. The dose found to be needed for adequate maintenance must be reasonably low, so that the occurrence of serious side-effects is not likely.
Indications for short-term therapy in rheumatoid arthritis will generally be to "cover" some special procedure in rehabilitation, such as manipulation. In such cases dosage must be carefully regulated, and reduced slowly and progressively. [The intra-articular use of hydrocortisone lies outside this discussion but its use in this way can be of great additional help in many cases of rheumatoid arthritis where the rate of joint improvement under oral therapy is uneven. ] We feel that following the original scmewhat uncritical acceptance of steroid therapy, the recent fashionable trend is to decry the use of these hormones unduly for long-term therapy. Such criticism tends to be based on only one or two reports which happen to have achieved considerable publicity. These have over-emphasized the possible dangers and complications of cortisone therapy.
One's opinion of a remedy must depend upon what one expects of it, and Dr. Duthie and I approach the matter from different angles. He as a clinical scientist, with a somewhat "perfectionist" outlook; myself from the more old-fashioned outlook of the clinician who sees what looks like a useful therapeutic tool and tries to find out how best it can be used to benefit his patients, despite its acknowledged imperfections. Under cortisone therapy patients still retain their imperfect joints, still suffer periodical exacerbations, and in the long run the structural damage to their locomotor system may even slowly increase under cover of these hormones. Nevertheless they can with its help be shielded from the most unpleasant effects of the disease, and so made more active, useful and happy members of society long after this would have ceased to be possible without its help. No one, I think, has ever claimed cortisone to be a cure for rheumatoid arthritis. Unfortunately there is no real cure as yet. But many groups who have worked in this field, including my own, consider that if it is intelligently used it can be of great help in the management of this difficult disease. If we cannot find a real cure, any agent which is none the less capable of producing a major suppression of symptoms in suitable cases by virtue of an anti-inflammatory action, however non-specific, is worth looking into carefully, and learning how best it can be used.
In rheumatoid arthritis cortisone will initially reverse most of those pathological changes which still remain reversible, and suppress the activity of the disease. There can, therefore, only be two valid Procee4ings of the Royal Sociy of Medicine 16 grounds for serious criticism;of its long-term use: (a) If it can be shown to be dangerous to the life-of the patient; or (b) If it can be shown to make the patient's disease worse at any stage. (It would niot even be sufficient to show that the beneficial effects were apt to wear off in time, as in that case the patient would ultimately be no worse off than prior to undertaking treatment.) (a) Danger to life.-This suggestion is chiefly based on two patients reported by West and Newns (1952) who died whilst on cortisone treatment. There seems to me to be no valid reason, however, for attributing their deaths actually to the treatment, as one died from amyloid disease, whilst the other died of gastro-intestinal heemorrhage after having developed a duodenal ulcer. Another possible complication is that suggested recently-but as yet quite unproven-that an atypical polyarteritis may develop in rheumatoid arthritis under treatment with cortisone.
That the symptoms of intercurrent medical or surgical emergencies may be dangerously masked has not been borne out in our expenence as we have been able to diagnose cases of pneumonia, peptic ulcers, local inflammations, and one case of strangulated hernia, in cases under treatment, without particular difficulty. The only real danger in our opinion occurs if the hormone is stopped suddenly in an emergency, as then suprarenal failure may be added to the effects of the emergency.
If unsuitable cases suffering with some well-known contra-indica tion such as incipient cardiac failuie, diabetes, hypertension, tuberculosis or psychosis are subjected to hormone treatment, disaster may follow. This circumstance, however, should never occur in the light of modern kniowledge.
(b) Exacerbation ofpatient's disease.-The patient's disease can certainly be badly exacerbated if cortisone is used and withdrawn improperly. Everyone working in this field, however, should be sufficiently aware of the dangers of these "rebound" and "withdrawal" plienomena to be able to avoid them. There are also certain well-accepted contra-indications to its use which have been mentioned already; and we have also found that women in the menopausal zone tolerate these hormones less well than other subjects.
Side-effects.-Our experience is that if treatment is properly supervised seriQus side-effects do not often occur; or if they do they can be dealt with, generally without having to discontinue treatment. Some of them, such as spontaneous fracture, are of such rarity that no specific case has been reported as yet in this country.
Duthie (1952) says that unspecified side-effects occur at some stage in 50% of all cases treated. Kendall (1951) states that 50% of patients receiving a dosage above 75 mg. daily will show slight sideeffects, but hardly any of these severe enough to influence treatment. Lowman (1953) is in agreement, but states that if the dosage is kept below 75 mg. daily only 21 % show these unimportant side-effects. Ward et al. (1953) report on 46 cases treated up to two years, and of these only 9 showed side-effects (some of more than one type), but none had to have his treatment stopped. Boland and Holten (1953) reporting on 40 patients, stated that treatment had in no case to be discontinued on account of side-effects.
In our own series of 20 cases treated for a period of up to three years (14 for more than two years), although all were unable to follow their occupations before treatment started, 17 were enabled to return to work, and in only 2 cases did we have to suspend treatment on account of late-occurring side-effects (hypertension and depression).
Finally, Dr. Duthie has drawn conclusions unfavourable to the use of cortisone from the interim report of the recent aspirin/cortisone trial conducted under the auspices of the Medical Research Council. My group took part in that, but we do not feel able to agree with Dr. Duthie's conclusions for the following reasons:
The cases selected for this series-which was not intended as a clinical trial-were early ones with few objective joint signs on which assessment could be based. These cases were, moreover, not specially selected for the purpose, which is essential if one is to obtain satisfactory results in clinical practice, but had to be selected at random in order to satisfy the requirements of subsequent statistical analysis. The dosage in the first few weeks was arbitrary, and the initial dosage unduly high in the light of modern experience. Perhaps the most important feature of all, however, had this been meant as an ordinary clinical assessment of the value of cortisone, was the statutory obligation to withdraw this substance suddenly every thirteen weeks for control purposes. This occasioned a severe relapse in nearly every case, which would have been avoided in patients who were being treated in the ordinary way.
We believe, therefore, that the clinician who has charge of patients with rheumatoid arthritis can find cortisone and ACTH of very great help in the long-term manament of certain carefully selected cases. A good deal of time and trouble will have to be expended, however, if favourable results are to be maintained.
